ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
August 29, 2024 16:50 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 29, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced completion of the merger with Oruka Therapeutics, Inc. (“Oruka”) following ARCA’s...
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
August 26, 2024 19:30 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 26, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced an update to the previously announced final amount of the special cash dividend...
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
August 23, 2024 16:30 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 23, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ: ABIO) (“ARCA”) today announced that its Board of Directors (the “Board”) has approved a reverse stock split of...
ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka Therapeutics
August 16, 2024 16:15 ET
|
ARCA biopharma, Inc.
Special dividend estimated to be $1.59 per share Payment of special dividend conditioned upon ARCA stockholder approval of the Proposed Merger with Oruka WESTMINSTER, Colo., Aug. 16, 2024 (GLOBE...
ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 01, 2024 16:15 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Aug. 01, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company applying a precision medicine approach to developing...
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
April 25, 2024 16:15 ET
|
ARCA biopharma, Inc.
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
April 03, 2024 07:30 ET
|
ARCA biopharma, Inc.
Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company...
ARCA biopharma Announces 2023 Financial Results
February 01, 2024 16:35 ET
|
ARCA biopharma, Inc.
ARCA biopharma Announces 2023 Financial Results
ARCA biopharma Announces Third Quarter 2023 Financial Results
October 18, 2023 16:25 ET
|
ARCA biopharma, Inc.
ARCA biopharma Announces Third Quarter 2023 Financial Results
ARCA biopharma Announces Second Quarter 2023 Financial Results
July 21, 2023 16:25 ET
|
ARCA biopharma, Inc.
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE...